Get back to your life in this historic town by visiting nearby Cambridge Biotherapies for specialized Ketamine and TMS treatment therapy for adults in Revere, MA. People who suffer from depression and other conditions and find no relief from traditional prescriptions need effective treatment more than anything. Ketamine and TMS are both cutting-edge treatments being used for depression and other mood disorders, particularly for those who have not been helped by traditional treatments. Our advanced treatments are proven to be highly effective options for severe symptoms, and we strive to develop specialized treatment plans to help find a solution that is best for you.
Intravenous Ketamine Therapy is an empirically validated and highly effective treatment that we offer in a safe, private, and comfortable setting, with highly qualified and supportive staff. Ketamine is administered as an IV infusion over a period of 40 minutes in small doses, to provide dramatic relief from the symptoms of depression, anxiety, and post-traumatic stress disorder (PTSD). The therapeutic effects of common antidepressant medications emerge only after 4-12 weeks of treatment. Ketamine, on the other hand, exerts rapid antidepressant effects following just a single infusion and the repeated administration of ketamine produces a more pronounced and longer-lasting effect.
If you're looking for a non-invasive, non-medication treatment option near Revere, MA, standard or accelerated Transcranial Magnetic Stimulation (TMS) offers a powerful approach for patients who have not benefited from traditional treatments such as psychotherapy and daily use of medication. At Cambridge Biotherapies we provide this FDA-cleared approach that is safe and twice as effective as traditional antidepressants for symptoms of depression and anxiety. This empirically validated TMS treatment can be used for patients suffering from depression, anxiety, anorexia nervosa, bulimia nervosa, bipolar disorder, obsessive-compulsive disorder, seasonal affective disorder, and post-traumatic stress disorder.